|
1
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu YH, Li ML, Hsu MY, Pang YY, Chen IL,
Chen CK, Tang SW, Lin HY and Lin JY: Effects of a Chinese herbal
medicine, Guan-Jen-Huang (Aeginetia indica Linn.), on renal cancer
cell growth and metastasis. Evid Based Complement Alternat Med.
2012:9358602012. View Article : Google Scholar
|
|
3
|
Huang M, Hu YY, Dong XQ, Xu QP, Yu WH and
Zhang ZY: The protective role of oxymatrine on neuronal cell
apoptosis in the hemorrhagic rat brain. J Ethnopharmacol.
143:228–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP
and Wu BY: Oxymatrine liposome attenuates hepatic fibrosis via
targeting hepatic stellate cells. World J Gastroenterol.
18:4199–4206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hong-Li S, Lei L, Lei S, Dan Z, De-Li D,
Guo-Fen Q, Yan L, Wen-Feng C and Bao-Feng Y: Cardioprotective
effects and underlying mechanisms of oxymatrine against ischemic
myocardial injuries of rats. Phytother Res. 22:985–989. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang
B and Zheng S: Oxymatrine induces human pancreatic cancer PANC-1
cells apoptosis via regulating expression of Bcl-2 and IAP
families, and releasing of cytochrome c. J Exp Clin Cancer Res.
30:662011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Anti-tumor activities of matrine and oxymatrine: Literature
review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song G, Luo Q, Qin J, Wang L, Shi Y and
Sun C: Effects of oxymatrine on proliferation and apoptosis in
human hepatoma cells. Colloids Surf B Biointerfaces. 48:1–5. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang D, Xiang DB, Yang XQ, Chen LS, Li MX,
Zhong ZY and Zhang YS: APE1 overexpression is associated with
cisplatin resistance in non-small cell lung cancer and targeted
inhibition of APE1 enhances the activity of cisplatin in A549
cells. Lung Cancer. 66:298–304. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Helleday T, Petermann E, Lundin C, Hodgson
B and Sharma RA: DNA repair pathways as targets for cancer therapy.
Nat Rev Cancer. 8:193–204. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kelley MR, Georgiadis MM and Fishel ML:
APE1/Ref-1 role in redox signaling: Translational applications of
targeting the redox function of the DNA repair/redox protein
APE1/Ref-1. Curr Mol Pharmacol. 5:36–53. 2012. View Article : Google Scholar :
|
|
12
|
Xanthoudakis S, Smeyne RJ, Wallace JD and
Curran T: The redox/DNA repair protein, Ref-1, is essential for
early embryonic development in mice. Proc Natl Acad Sci USA.
93:8919–8923. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindahl T: Instability and decay of the
primary structure of DNA. Nature. 362:709–715. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dianov GL, Sleeth KM, Dianova II and
Allinson SL: Repair of abasic sites in DNA. Mutat Res. 531:157–163.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bapat A, Glass LS, Luo M, Fishel ML, Long
EC, Georgiadis MM and Kelley MR: Novel small-molecule inhibitor of
apurinic/apyrimidinic endonuclease 1 blocks proliferation and
reduces viability of glioblastoma cells. J Pharmacol Exp Ther.
334:988–998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu C, Huang W, Guo Y, Xia P, Sun X, Pan X
and Hu W: Oxymatrine inhibits the proliferation of prostate cancer
cells in vitro and in vivo. Mol Med Rep. 11:4129–4134.
2015.PubMed/NCBI
|
|
17
|
Wei J, Zhu Y, Xu G, Yang F, Guan Z, Wang M
and Fang Y: Oxymatrine extracted from Sophora flavescens inhibited
cell growth and induced apoptosis in human osteosarcoma MG-63 cells
in vitro. Cell Biochem Biophys. 70:1439–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Hou X, Fu H, Pan X, Xu W, Tang W
and Fang H: Design, synthesis and preliminary bioactivity
evaluations of substituted quinoline hydroxamic acid derivatives as
novel histone deacetylase (HDAC) inhibitors. Bioorg Med Chem.
23:4364–4374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valdiglesias V, Giunta S, Fenech M, Neri M
and Bonassi S: γH2AX as a marker of DNA double strand breaks and
genomic instability in human population studies. Mutat Res.
753:24–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schreiber V, Dantzer F, Ame JC and de
Murcia G: Poly(ADP-ribose): Novel functions for an old molecule.
Nat Rev Mol Cell Biol. 7:517–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muñoz-Gámez JA, Rodríguez-Vargas JM,
Quiles-Pérez R, Aguilar-Quesada R, Martín-Oliva D, de Murcia G,
Menissier de Murcia J, Almendros A, Ruiz de Almodóvar M and Oliver
FJ: PARP-1 is involved in autophagy induced by DNA damage.
Autophagy. 5:61–74. 2009. View Article : Google Scholar
|
|
22
|
Krishnakumar R and Kraus WL: The PARP side
of the nucleus: Molecular actions, physiological outcomes, and
clinical targets. Mol Cell. 39:8–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Scott TL, Rangaswamy S, Wicker CA and
Izumi T: Repair of oxidative DNA damage and cancer: Recent progress
in DNA base excision repair. Antioxid Redox Signal. 20:708–726.
2014. View Article : Google Scholar :
|
|
24
|
Evans AR, Limp-Foster M and Kelley MR:
Going APE over ref-1. Mutat Res. 461:83–108. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Madhusudan S, Smart F, Shrimpton P,
Parsons JL, Gardiner L, Houlbrook S, Talbot DC, Hammonds T,
Freemont PA, Sternberg MJ, et al: Isolation of a small molecule
inhibitor of DNA base excision repair. Nucleic Acids Res.
33:4711–4724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song MQ, Zhu JS, Chen JL, Wang L, Da W,
Zhu L and Zhang WP: Synergistic effect of oxymatrine and
angiogenesis inhibitor NM-3 on modulating apoptosis in human
gastric cancer cells. World J Gastroenterol. 13:1788–1793. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu
W, Qi X, Zhu X, Pei Y and Lin H: Oxymatrine diminishes the side
population and inhibits the expression of β-catenin in MCF-7 breast
cancer cells. Med Oncol. 28(Suppl 1): S99–S107. 2011. View Article : Google Scholar
|
|
28
|
Fishel ML and Kelley MR: The DNA base
excision repair protein Ape1/Ref-1 as a therapeutic and
chemopreventive target. Mol Aspects Med. 28:375–395. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Qing Y, Guan W, Li M, Peng Y, Zhang
S, Xiong Y and Wang D: Predictive value of APE1, BRCA1, ERCC1 and
TUBB3 expression in patients with advanced non-small cell lung
cancer (NSCLC) receiving first-line platinum-paclitaxel
chemotherapy. Cancer Chemother Pharmacol. 74:777–786. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Izumi T, Hazra TK, Boldogh I, Tomkinson
AE, Park MS, Ikeda S and Mitra S: Requirement for human AP
endonuclease 1 for repair of 3′-blocking damage at DNA
single-strand breaks induced by reactive oxygen species.
Carcinogenesis. 21:1329–1334. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Silber JR, Bobola MS, Blank A, Schoeler
KD, Haroldson PD, Huynh MB and Kolstoe DD: The
apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1
contributes to human glioma cell resistance to alkylating agents
and is elevated by oxidative stress. Clin Cancer Res. 8:3008–3018.
2002.PubMed/NCBI
|
|
32
|
Kunkel TA: The high cost of living. In:
American Association for Cancer Research Special Conference:
Endogenous sources of mutations; Fort Myers, Florida, USA. 11–15
November 1998; Trends Genet. 15. pp. 93–94. 1999
|
|
33
|
Loeb LA and Preston BD: Mutagenesis by
apurinic/apyrimidinic sites. Annu Rev Genet. 20:201–230. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bjelland S, Anensen H, Knaevelsrud I and
Seeberg E: Cellular effects of 5-formyluracil in DNA. Mutat Res.
486:147–154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Georgakilas AG, O’Neill P and Stewart RD:
Induction and repair of clustered DNA lesions: What do we know so
far? Radiat Res. 180:100–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Prabhulkar S and Li CZ: Assessment of
oxidative DNA damage and repair at single cellular level via
real-time monitoring of 8-OHdG biomarker. Biosens Bioelectron.
26:1743–1749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim J, Cha YN and Surh YJ: A protective
role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in
inflammatory disorders. Mutat Res. 690:12–23. 2010. View Article : Google Scholar
|
|
38
|
Bapat A, Fishel ML and Kelley MR: Going
ape as an approach to cancer therapeutics. Antioxid Redox Signal.
11:651–668. 2009. View Article : Google Scholar :
|
